Study Finds Ablation To Be Superior For Atrial Fibrillation In Patients With Heart Failure Interview with:

Nassir F. Marrouche, MD Professor, Internal Medicine Cardiology University of Utah

Dr. Marrouche

Nassir F. Marrouche, MD
Professor, Internal Medicine
University of Utah What is the background for this study?

Response: Study the effectiveness of catheter ablation of Atrial Fibrillation in patients with heart failure in improving hard primary endpoints of mortality and heart failure progression when compared to conventional standard treatment What are the main findings?

 Catheter ablation of atrial fibrillation in patients with heart failure is associated with improved all-cause mortality and fewer admissions for worsening heart failure when compared to conventional standard of care treatment What should readers take away from your report?

Response: Ablation is safe, efficient and should be considered first line therapy in patients with heart failure. Avoid the use of antiarrhytmics. Early intervention is important What recommendations do you have for future research as a result of this study?

Response: Study effect of ablation on patients with normal heart, other co-morbbidities. What is the effect of new heart failure drugs on ablation outcome? Thank you for your contribution to the community.


ESC 2017 presentation and abstract:

Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial

Presented by Dr. Nassir Marrouche at the European Society of Cardiology Congress, Barcelona, Spain, August 27, 2017.

Note: Content is Not intended as medical advice. Please consult your health care provider regarding your specific medical condition and questions.

[wysija_form id=”5″]



Last Updated on September 7, 2017 by Marie Benz MD FAAD